Higher beta-hydroxybutyrate ketone levels associated with a slower kidney function decline in ADPKD
Martine Knol(University Medical Center Groningen), Esther Meijer(University Medical Center Groningen), Dorien J.M. Peters(Leiden University Medical Center), Tom Nijenhuis(Radboud University Nijmegen), Ewout J. Hoorn(Erasmus MC), Mahdi Salih(Erasmus MC), Stephan J. L. Bakker(University Medical Center Groningen), Johan W. de Fijter(Antwerp University Hospital), Joost P.H. Drenth(Amsterdam Neuroscience), Maatje D.A. van Gastel(University Medical Center Groningen), Paul Geertsema(University Medical Center Groningen), Margery A. Connelly(Brigham and Women's Hospital), Thomas Bais(University Medical Center Groningen), Ron T. Gansevoort(University Medical Center Groningen)
Cited by 15
Related Papers
The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report
|Kidney International|2010|2.3k
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe
|European Heart Journal|2021|1.7k
World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions
|The Lancet Global Health|2019|1.2k
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k